Healthcare -
Biotechnology - NASDAQ - US
$ 1.18
3.51 %
$ 92.7 M
Market Cap
-1.76
P/E
SLS - OPERATING INCOME
Operating Income SLS - SELLAS Life Sciences Group, Inc.
-37.9 M
LAST VALUE
-22.36%
2 YEAR CAGR
-4.02%
5 YEAR CAGR
-1.13%
10 YEAR CAGR